$156.39
Price
$15.7B
Market Cap
24.1
P/E Ratio
12.3
Forward P/E
$6.49
EPS (TTM)
—
Dividend Yield
$1.3B
Cash
$415M
Total Debt
101M
Shares Out
$121.42
$162.39
52-Week Range
Institutional Ownership of NEUROCRINE BIOSCIENCES INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for NEUROCRINE BIOSCIENCES INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for NEUROCRINE BIOSCIENCES INC
6 Months Insider Sentiment
Buy $0
Sell $3.9M
0
Buys
4
Sells
-3.9M
Net
0
Grants
Largest
$2.3M
A
$764K
Norwalk
$761K
Norwalk
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 08, 2026 | Darin Lippoldt | Chief Legal Officer | EXERCISE | 3.3K | $35.99 | $121K |
| Dec 16, 2025 | Leslie V Norwalk | Director | SELL | 1.2K | $155.09 | $185K |
| Dec 15, 2025 | Leslie V Norwalk | Director | EXERCISE | 1.7K | $84.95 | $146K |
| Dec 15, 2025 | Leslie V Norwalk | Director | EXERCISE | 8.3K | $92.35 | $764K |
| Dec 15, 2025 | Leslie V Norwalk | Director | SELL | 5.0K | $152.23 | $761K |
| Dec 08, 2025 | Darin Lippoldt | Chief Legal Officer | EXERCISE | 4.4K | $43.24 | $189K |
| Dec 08, 2025 | Darin Lippoldt | Chief Legal Officer | SELL | 4.4K | $159.65 | $699K |
| Dec 03, 2025 | LYONS GARY A | Director | SELL | 15.0K | $152.61 | $2.3M |
| Dec 03, 2025 | LYONS GARY A | Director | EXERCISE | 15.0K | $47.89 | $718K |